Dolby Laboratories (DLB) Change in Accured Expenses (2009 - 2026)

Dolby Laboratories has reported Change in Accured Expenses for 18 years, with the latest figure at $39.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 74.95% year-over-year to $39.3 million; the trailing twelve-month figure through Mar 2026 stood at $78.5 million (up 799.88% YoY), and the FY2025 full-year result was $22.9 million, up 166.13% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $39.3 million, down from $43.6 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $71.8 million in Q3 2025, with the low at -$105.3 million in Q2 2023.
• Historically, Change in Accured Expenses has averaged $1.1 million across 5 years, with a median of $7.7 million in 2022.
• The largest YoY upside for Change in Accured Expenses was 935.69% in 2023 against a maximum downside of 1469.91% in 2023.
• Dolby Laboratories' Change in Accured Expenses stood at $5.8 million in 2022, then sank by 654.95% to -$32.0 million in 2023, then surged by 115.02% to $4.8 million in 2024, then soared by 807.06% to $43.6 million in 2025, then dropped by 9.82% to $39.3 million in 2026.
• The last three Change in Accured Expenses figures came in at $39.3 million (Q1 2026), $43.6 million (Q4 2025), and $71.8 million (Q3 2025), per Business Quant data.